www.sciencedirect.com Open in urlscan Pro
162.159.130.81  Public Scan

Submitted URL: https://doi.org/10.1016/j.ctim.2014.11.003
Effective URL: https://www.sciencedirect.com/science/article/abs/pii/S096522991400185X?via%3Dihub
Submission: On January 26 via api from US — Scanned from DE

Form analysis 1 forms found in the DOM

GET /search#submit

<form class="QuickSearch" action="/search#submit" method="get" aria-label="form"><input type="search" class="query" aria-label="Search ScienceDirect" name="qs" placeholder="Search ScienceDirect"><button class="button button-primary" type="submit"
    aria-label="Submit search"><span class="button-text"><svg role="img" focusable="false" viewBox="0 0 100 128" height="20" width="18.75" class="icon icon-search" aria-label="Search">
        <title>Search</title>
        <path
          d="m19.22 76.91c-5.84-5.84-9.05-13.6-9.05-21.85s3.21-16.01 9.05-21.85c5.84-5.83 13.59-9.05 21.85-9.05 8.25 0 16.01 3.22 21.84 9.05 5.84 5.84 9.05 13.6 9.05 21.85s-3.21 16.01-9.05 21.85c-5.83 5.83-13.59 9.05-21.84 9.05-8.26 0-16.01-3.22-21.85-9.05zm80.33 29.6l-26.32-26.32c5.61-7.15 8.68-15.9 8.68-25.13 0-10.91-4.25-21.17-11.96-28.88-7.72-7.71-17.97-11.96-28.88-11.96s-21.17 4.25-28.88 11.96c-7.72 7.71-11.97 17.97-11.97 28.88s4.25 21.17 11.97 28.88c7.71 7.71 17.97 11.96 28.88 11.96 9.23 0 17.98-3.07 25.13-8.68l26.32 26.32 7.03-7.03">
        </path>
      </svg></span></button><input type="hidden" name="origin" value="article"><input type="hidden" name="zone" value="qSearch"></form>

Text Content

JavaScript is disabled on your browser. Please enable JavaScript to use all the
features on this page. Skip to main content Skip to article
ScienceDirect
 * Journals & Books

 * Help
 * Search

RegisterSign in

PDF
View PDF
 * Access through your institution
 * Purchase PDF

Search


ARTICLE PREVIEW

 * Abstract
 * Introduction
 * Section snippets
 * References (25)
 * Cited by (5)
 * Recommended articles (6)


COMPLEMENTARY THERAPIES IN MEDICINE

Volume 23, Issue 4, August 2015, Pages 612-616




A CASE-CONTROL, MONO-CENTER, OPEN-LABEL, PILOT STUDY TO EVALUATE THE FEASIBILITY
OF THERAPEUTIC TOUCH IN PREVENTING RADIATION DERMATITIS IN WOMEN WITH BREAST
CANCER RECEIVING ADJUVANT RADIATION THERAPY

Author links open overlay
panelJawaidYounusaPersonEnvelopeMichaelLockbOlgaVujovicbEdwardYubJitkaMaleccDavidD'SouzacLarryStittd
Show moreNavigate Down
PlusAdd to Mendeley
ShareShare
Cited ByCite
https://doi.org/10.1016/j.ctim.2014.11.003Get rights and content




SUMMARY


BACKGROUND

Therapeutic touch (TT) is a non-invasive commonly used complementary therapy. TT
is based on the use of hand movements and detection of energy field congestion
to correct imbalances. Improvement in subjective symptoms in a variety of
clinical trials has been seen with TT. The effect of TT during radiotherapy for
breast cancer is unknown.


METHODS

Women undergoing adjuvant radiation for Stage I/II breast cancer post
conservative surgery were recruited for this cohort study. TT treatments were
administered three times per week following radiation therapy. Feasibility was
defined as an a priori threshold of 15 of 17 patients completing all TT
treatments. The preventive effectiveness of TT was evaluated by documenting the
‘time to develop’ and the ‘worst grade of radiation’ dermatitis. Toxicity was
assessed using NCIC CTC V3 dermatitis scale. Cosmetic rating was performed using
the EORTC Breast Cosmetic Rating. The quality of life, mood and energy, and
fatigue were assessed by EORTC QLQ C30, POMS, and BFI, respectively. The
parameters were assessed at baseline, and serially during treatment.


RESULTS

A total of 49 patients entered the study (17 in the TT Cohort and 32 in the
Control Cohort). Median age in TT arm was 63 years and in control arm was 59
years. TT was considered feasible as all 17 patients screened completed TT
treatment. There were no side effects observed with the TT treatments. In the TT
Cohort, the worst grade of radiation dermatitis was grade II in nine patients
(53%). Median time to develop the worst grade was 22 days. In the Control
Cohort, the worst grade of radiation dermatitis was grade III in 1 patient.
However, the most common toxicity grade was II in 15 patients (47%). Three
patients did not develop any dermatitis. Median time to develop the worst grade
in the control group was 31 days. There was no difference between cohorts for
the overall EORTC cosmetic score and there was no significant difference in
before and after study levels in quality of life, mood and fatigue.


CONCLUSION

This study is the first evaluation of TT in patients with breast cancer using
objective measures. Although TT is feasible for the management of radiation
induced dermatitis, we were not able to detect a significant benefit of TT on
NCIC toxicity grade or time to develop the worst grade for radiation dermatitis.
In addition, TT did not improve quality of life, mood, fatigue and overall
cosmetic outcome.


INTRODUCTION

Therapeutic Touch (TT) is the current term used for an ancient practice called
the “laying of hands” commonly used in a variety of settings. However, this is a
misnomer since the intervention does not necessarily require any direct patient
touching. It is based on a belief that every living organism has an energy field
around it that produces an aura. This energy field can go unbalanced when the
living organism is sick and healers can feel and manipulate this energy field by
movement of hands over the patient's body just like massaging the air few inches
above the patient's body. This process usually lasts 10–20 min depending on the
practitioner's ability to detect these imbalances and the amount of areas with
energy congestion.1 This primal life energy imbalance can be corrected according
to TT practitioners. Furthermore, this channeling of vital energy can assist
healing; a concept common in Ayurvedic medicine and healing systems found in
India, China, Japan, and Greece where it is called prana, chi, ki, or pneuma,
respectively.1, 2

According to the Cochcrane Collaboration, TT was first popularized by Dr.
Krieger, a research nursing professor at New York University. A literature
search using the MESH heading ‘therapeutic touch’ identifies 847 articles with
178 published within the last 5 years.3 TT at present is taught in 75 schools
and universities and at 95 health care facilities in North America.4 Training is
available in over 70 countries through institutions such as The American Nurses
Association.4

There are no known side effects related to the use of TT. Most of the previous
trials on TT have demonstrated subjective symptom improvement in a variety of
clinical situations, including anxiety, pain and other related symptoms. The
rationale for this study stemmed from clinical trials, which demonstrated
improvement in wound healing with TT.2, 5

Relative to many alternative therapies, the demonstration of a quantifiable
objective response is an interesting and impressive aspect of TT that calls for
further investigation. Radiation induced dermatitis is a common problem in a
significant proportion of patients treated with radiation. In addition, it is a
quantifiable complication, easily observed and graded according to National
Cancer Institute criteria for toxicity. Therefore, we opted to investigate TT to
assess its ability to prevent radiation dermatitis associated with adjuvant
radiation therapy for early breast cancer.


SECTION SNIPPETS


PATIENT SELECTION

A single institution, ethics review board approved, prospective case-cohort
study was conducted in patients with histo-pathologically or cytologically
confirmed diagnosis of breast cancer, scheduled to receive adjuvant tangent
radiation therapy as outpatients at the London Regional Cancer Program, London,
Ontario. Female patients between 18 and 80 years of age at the time of
enrollment and who had completed lumpectomy and sentinel lymph node biopsy or
axillary lymph node dissection were


RESULTS

From a total of 49 patients, the TT group comprised of 17 patients with the
median age of 63 years, while 32 patients were included in the control group
with median age of 59 years. All patients in both groups had lumpectomy. The
details on tumor size, lymph node evaluation, hormone receptor and Her-2Neu
status are summarized in Table 1. The Eastern Cooperative Oncology Group (ECOG)
performance status was 0–1 in all the patients.

Our primary objective was feasibility of introducing this


DISCUSSION

Therapeutic touch was brought to mainstream medical attention by Dolores
Krieger, Ph.D., R.N., a faculty member at New York University's Division of
Nursing, who began TT in the early 1970s. Soon afterwards TT was learned and
used by nurses as an adjunct to patient care. Interestingly, the first phase of
research began in the 1960s with studies examining the effects of TT on plant
growth and wound healing in mice.21 However in the 1970s Dora Kunz and Dolores
Krieger were among the first to use


CONCLUSIONS

This study is the first evaluation of TT in patients with breast cancer using
objective measures. Introduction of this alternative therapy into a
comprehensive cancer clinic was feasible and acceptable. While there were no
side effects observed, we were not able to detect a significant benefit of TT on
NCIC toxicity grade or time to develop radiation dermatitis. In addition, TT did
not improve quality of life, overall mood, fatigue and overall cosmetic outcome.


CONFLICT OF INTEREST

This is to certify that all authors have seen and approved the manuscript
submitted and have no conflicts of interest.




REFERENCES (25)

 * A.L. Schwartz et al.
   
   
   MEASUREMENT OF FATIGUE. DETERMINING MINIMALLY IMPORTANT CLINICAL DIFFERENCES
   
   
   J CLIN EPIDEMIOL
   
   (2002)
 * A. Trotti et al.
   
   
   CTCAE V 3.0: DEVELOPMENT OF A COMPREHENSIVE GRADING SYSTEM FOR THE ADVERSE
   EFFECTS OF CANCER TREATMENT
   
   
   SEMINRAD.ONC
   
   (2003)
 * D. Krieger
   
   
   THE THERAPEUTIC TOUCH: HOW TO USE YOUR HANDS TO HELP OR HEAL
   
   (1979)
 * D.P. O'Mathuna
   
   
   THERAPEUTIC TOUCH: WHAT COULD BE THE HARM?
   
   
   SCIENTIFIC REVIEW OF ALTERNATE MEDICINE
   
   (1998)
 * US National Library of Medicine. PubMed.Gov. Accessed August 15,...
 * D.P. O'Mathuna et al.
   
   
   THERAPEUTIC TOUCH FOR HEALING ACUTE WOUNDS
   
   
   COCHRANE DATABASE SYST REV
   
   (2014)
 * J.A. Astin et al.
   
   
   THE EFFICACY OF DISTANT HEALING: A SYSTEMATIC REVIEW OF RANDOMIZED TRIALS
   
   
   ANN INTERN MED
   
   (2000)
 * N.K. Aaronson et al.
   
   
   THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QLQ-C30: A
   QUALITY OF LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL TRIALS IN
   ONCOLOGY
   
   
   J NATL CANCER INST
   
   (1993)
 * J. Dancey et al.
   
   
   QUALITY OF LIFE SCORES: AN INDEPENDENT PROGNOSTIC VARIABLE IN A GENERAL
   POPULATION OF CANCER PATIENTS RECEIVING CHEMOTHERAPY. THE NATIONAL CANCER
   INSTITUTE OF CANADA CLINICAL TRIALS GROUP
   
   
   QUAL LIFE RES
   
   (1997)
 * H.E. Niezgoda et al.
   
   
   A VALIDATION STUDY OF THE DOMAINS OF THE CORE EORTC QUALITY OF LIFE
   QUESTIONNAIRE
   
   
   QUAL LIFE RES
   
   (1993)

G.I. Ringdal et al.


TESTING THE EORTC QUALITY OF LIFE QUESTIONNAIRE ON CANCER PATIENTS WITH
HETEROGENOUS DIAGNOSES


QUAL LIFE RES

(1993)
F. Baker et al.


A POMS SHORT FORM FOR CANCER PATIENTS: PYSCHOMETRIC AND STRUCTURAL EVALUATION


PSYCHOONCOLOGY

(2002)
Navigate DownView more references


CITED BY (5)


 * EFFECT OF THERAPEUTIC TOUCH ON SLEEP QUALITY AND ANXIETY IN INDIVIDUALS WITH
   CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RANDOMIZED CONTROLLED TRIAL
   
   2021, Complementary Therapies in Clinical Practice
   Show abstractNavigate Down
   
   The purpose is to determine the effect of therapeutic touch (TT) on the sleep
   quality and anxiety of individuals with chronic obstructive pulmonary (COPD)
   disease.
   
   103 patients were randomized in to the two groups: the experimental group,
   and the control group. In this randomized control study, the patients with
   COPD in the experimental group were given TT for 10 min between 18:00 and
   20:00, one session every day for three consecutive days.
   
   When the experimental group was compared to control group following the
   intervention, the decrease in the levels of anxiety (p < 0.001) and increase
   in the sleep quality (p < 0.001) were found to be significant.
   
   As a result of the study, it was determined that TT reduced anxiety level and
   improved sleep quality in individuals with chronic obstructive pulmonary
   disease. The Clinical Trial Registration Number: NCT04842903.


 * EFFECT OF THERAPEUTIC TOUCH ON DAYTIME SLEEPINESS, STRESS AND FATIGUE AMONG
   STUDENTS OF NURSING AND MIDWIFERY: A RANDOMIZED SHAM-CONTROLLED TRIAL
   
   2021, Complementary Therapies in Clinical Practice
   Show abstractNavigate Down
   
   This study was conducted to assess the effect of therapeutic touch on stress,
   daytime sleepiness, sleep quality and fatigue among students of nursing and
   midwifery.
   
   96 students were randomized into three groups: the therapeutic touch (TT)
   group, the sham therapeutic touch (STT) group, and the control group. In this
   randomized sham-controlled study, the TT group was subjected to therapeutic
   touch twice a week for four weeks with each session lasting 20 min.
   
   When the TT group was compared to the STT and control groups following the
   intervention, the decrease in the levels of stress (p < 0.001), fatigue
   (p < 0.001) and daytime sleepiness (p < 0.001), and the increase in the sleep
   quality (p < 0.001) were found to be significant.
   
   It was found that TT, which is one form of complementary therapy, was
   relatively effective in decreasing the levels of stress, fatigue and daytime
   sleepiness, and in increasing the sleep quality of university students of
   nursing and midwifery.


 * A RAPID EVIDENCE ASSESSMENT OF RECENT THERAPEUTIC TOUCH RESEARCH
   
   2021, Nursing Open
   
   


 * WHAT INFLUENCE DOES THE THERAPEUTIC TOUCH HAVE ON BREAST CANCER?
   
   2021, Medicina Interna de Mexico
   
   


 * PREDICTORS AND QUALITY OF LIFE IN PATIENTS WITH RADIODERMATITIS: A
   LONGITUDINAL STUDY
   
   2021, ACTA Paulista de Enfermagem
   
   


RECOMMENDED ARTICLES (6)

 * Research article
   
   
   PROSPECTIVE EVALUATION OF SEVERE SKIN TOXICITY AND PAIN DURING POSTMASTECTOMY
   RADIATION THERAPY
   
   International Journal of Radiation Oncology*Biology*Physics, Volume 91, Issue
   1, 2015, pp. 157-164
   Show abstractNavigate Down
   
   To prospectively capture acute toxicities and pain associated with
   postmastectomy radiation therapy (PMRT), to analyze patient and treatment
   risk factors for severe side effects.
   
   Women referred for PMRT were prospectively enrolled and assessed weekly
   during and after radiation therapy. The endpoint included severe National
   Cancer Institute Common Terminology Criteria for Adverse Effects grade 3
   moist desquamation, other skin symptoms, and pain.
   
   Of 257 patients, 73 (28.4%) experienced extensive moist desquamation, 84
   (32.7%) Common Terminology Criteria for Adverse Effects skin toxicity grade
   3, and 57 (22.2%) a pain impacting on daily life activities. Among symptoms
   only grade 3 moist desquamation was significantly associated with severe pain
   (P<.001). On multivariate analysis, smoking, high-energy photons, and skin
   bolus were significantly associated with severe moist desquamation. Skin
   toxicity doubled for smokers, with 40% severe pain, 48% grade 3 moist
   desquamation, and 64% grade 3 skin toxicity. Without skin bolus 4.2% had
   severe pain, none moist desquamation, and 2.1% grade 3 skin toxicity. When
   skin bolus was used on alternate days, the frequency increased to 15% for
   pain, 22% for moist desquamation, and 26% for grade 3 skin toxicity. When
   bolus was used daily, 32% had pain, 41% moist desquamation, and 47% grade 3
   skin toxicity. Symptoms peaked 1 to 2 weeks after the end of PMRT.
   
   The present cohort study suggests excessive radiation toxicity after PMRT.
   Among factors associated with an increase of toxicity are smoking habits and
   the use of skin bolus.

 * Research article
   
   
   IN SILICO INSTRUMENTAL RESPONSE CORRECTION IMPROVES PRECISION OF LABEL-FREE
   PROTEOMICS AND ACCURACY OF PROTEOMICS-BASED PREDICTIVE MODELS
   
   Molecular & Cellular Proteomics, Volume 12, Issue 8, 2013, pp. 2324-2331
   Show abstractNavigate Down
   
   In the analysis of proteome changes arising during the early stages of a
   biological process (e.g. disease or drug treatment) or from the indirect
   influence of an important factor, the biological variations of interest are
   often small (∼10%). The corresponding requirements for the precision of
   proteomics analysis are high, and this often poses a challenge, especially
   when employing label-free quantification. One of the main contributors to the
   inaccuracy of label-free proteomics experiments is the variability of the
   instrumental response during LC-MS/MS runs. Such variability might include
   fluctuations in the electrospray current, transmission efficiency from the
   air–vacuum interface to the detector, and detection sensitivity. We have
   developed an in silico post-processing method of reducing these variations,
   and have thus significantly improved the precision of label-free proteomics
   analysis. For abundant blood plasma proteins, a coefficient of variation of
   approximately 1% was achieved, which allowed for sex differentiation in
   pooled samples and ≈90% accurate differentiation of individual samples by
   means of a single LC-MS/MS analysis. This method improves the precision of
   measurements and increases the accuracy of predictive models based on the
   measurements. The post-acquisition nature of the correction technique and its
   generality promise its widespread application in LC-MS/MS-based methods such
   as proteomics and metabolomics.

 * Research article
   
   
   TURKISH WOMEN'S KNOWLEDGE AND VIEWS REGARDING MOTHER'S MILK BANKING
   
   Collegian, Volume 21, Issue 3, 2014, pp. 239-244
   Show abstractNavigate Down
   
   The main aim of the study was to determine the knowledge and views of Eastern
   Anatolian women towards mother's milk banking.
   
   The descriptive research was conducted between March and May 2009. The study
   population comprised 350 married women aged between 15 and 49 years who gave
   birth and who were registered with a family health center in Erzurum, Turkey.
   The data were collected by a questionnaire form. The questionnaire form
   included open-ended and closed questions regarding the descriptive
   characteristics and about knowledge and views of mothers on milk banking. The
   questionnaire form was completed by the women individually.
   
   Of the women surveyed, 90.6% indicated they had not previously heard anything
   about breast milk banking, 64.0% said that they could donate their milk,
   36.3% stated it constituted a problem from a religious aspect, and 28.9% said
   it leads to social and moral problems.
   
   The hospital and maternity authorities may consider establishing a “milk
   mother file”. This report addresses the first step in raising awareness of
   the valuable contribution of donor milk to babies and the organization of
   human milk donation for use in a neonatal intensive care unit.

 * Research article
   
   
   MANAGEMENT OF ACUTE RADIATION DERMATITIS: A REVIEW OF THE LITERATURE AND
   PROPOSAL FOR TREATMENT ALGORITHM
   
   Journal of the American Academy of Dermatology, Volume 81, Issue 2, 2019, pp.
   558-567
   Show abstractNavigate Down
   
   Radiation dermatitis is a common sequela of radiation therapy; up to 95% of
   patients will develop moderate-to-severe skin reactions. No criterion
   standard currently exists for the treatment of acute radiation-induced skin
   toxicity. It is therefore imperative to develop a greater understanding of
   management options available to allow clinicians to make informed decisions
   when managing radiation oncology patients. This literature review discusses
   the topical agents that have been studied for the treatment of acute
   radiation dermatitis, reviews their mechanisms of action, and presents a
   treatment algorithm for clinicians managing patients experiencing radiation
   dermatitis.

 * Research article
   
   
   CHARACTERIZING THE EFFECTS OF RADIATION DERMATITIS ON QUALITY OF LIFE: A
   PROSPECTIVE SURVEY-BASED STUDY
   
   Journal of the American Academy of Dermatology, Volume 86, Issue 1, 2022, pp.
   161-163
   
   
 * Research article
   
   
   CLOSING THE GAP BETWEEN RESEARCH AND PRACTICE: IS IT THE KEY TO INCREASING
   THE IMPACT OF CAM RESEARCH?
   
   Complementary Therapies in Medicine, Volume 23, Issue 4, 2015, pp. 635-636
   
   


View full text
Copyright © 2014 Elsevier Ltd. All rights reserved.

 * About ScienceDirect
 * Remote access
 * Shopping cart
 * Advertise
 * Contact and support
 * Terms and conditions
 * Privacy policy

We use cookies to help provide and enhance our service and tailor content and
ads. By continuing you agree to the use of cookies.

Copyright © 2023 Elsevier B.V. or its licensors or contributors. ScienceDirect®
is a registered trademark of Elsevier B.V.

ScienceDirect® is a registered trademark of Elsevier B.V.